Clinical Trials Logo

Clinical Trial Summary

The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.


Clinical Trial Description

The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.

Specifically, we propose to conduct a clinical trial to compare the effects of a prostate decision dashboard versus usual care on:

1. patient knowledge regarding the treatment options available for low or intermediate risk prostate cancer,

2. measures of the decision making process including decisional conflict and the extent to which decisions were made via a shared decision making process,

3. the treatments selected, and

4. 3-6 and 9-12 month outcome assessments of clinical status, decision regret, cancer-related quality of life including worry, functional status, and treatment side effects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02342626
Study type Interventional
Source University of Rochester
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date December 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02258087 - HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer. Phase 2/Phase 3
Recruiting NCT04687969 - Multimodal Machine Learning Characterization of Solid Tumors
Recruiting NCT02672449 - Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer N/A
Active, not recruiting NCT01913717 - Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion N/A
Completed NCT02025361 - Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy Phase 4
Completed NCT00140478 - Mifepristone (RU-486) in Androgen Independent Prostate Cancer Phase 2
Active, not recruiting NCT01952223 - A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse Phase 3
Completed NCT03518853 - Short Course Radiotherapy for Localized Prostate Cancer N/A
Active, not recruiting NCT01994239 - Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy Phase 2
Terminated NCT02024685 - Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial N/A